These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22048796)

  • 1. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis.
    Lip GY; Andreotti F; Fauchier L; Huber K; Hylek E; Knight E; Lane D; Levi M; Marín F; Palareti G; Kirchhof P;
    Thromb Haemost; 2011 Dec; 106(6):997-1011. PubMed ID: 22048796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
    Lip GY; Andreotti F; Fauchier L; Huber K; Hylek E; Knight E; Lane DA; Levi M; Marin F; Palareti G; Kirchhof P; ; Collet JP; Rubboli A; Poli D; Camm J
    Europace; 2011 May; 13(5):723-46. PubMed ID: 21515596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.
    Gorog DA; Gue YX; Chao TF; Fauchier L; Ferreiro JL; Huber K; Konstantinidis SV; Lane DA; Marin F; Oldgren J; Potpara T; Roldan V; Rubboli A; Sibbing D; Tse HF; Vilahur G; Lip GYH
    Europace; 2022 Nov; 24(11):1844-1871. PubMed ID: 35323922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
    Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
    Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen JK; Cuisset T; Kirchhof P; Marín F;
    Eur Heart J; 2010 Jun; 31(11):1311-8. PubMed ID: 20447945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS).
    Sticherling C; Marin F; Birnie D; Boriani G; Calkins H; Dan GA; Gulizia M; Halvorsen S; Hindricks G; Kuck KH; Moya A; Potpara T; Roldan V; Tilz R; Lip GY
    Europace; 2015 Aug; 17(8):1197-214. PubMed ID: 26105732
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.
    Gorog DA; Gue YX; Chao TF; Fauchier L; Ferreiro JL; Huber K; Konstantinidis SV; Lane DA; Marin F; Oldgren J; Potpara T; Roldan V; Rubboli A; Sibbing D; Tse HF; Vilahur G; Lip GYH
    Thromb Haemost; 2022 Oct; 122(10):1625-1652. PubMed ID: 35793691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA;
    Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallel.
    Rohla M; Weiss TW; Wojta J; Niessner A; Huber K
    Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):191-7. PubMed ID: 27533995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting.
    Wrigley BJ; Tapp LD; Shantsila E; Lip GY
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):290-3. PubMed ID: 20693960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
    Lip GY; Windecker S; Huber K; Kirchhof P; Marin F; Ten Berg JM; Haeusler KG; Boriani G; Capodanno D; Gilard M; Zeymer U; Lane D; ; Storey RF; Bueno H; Collet JP; Fauchier L; Halvorsen S; Lettino M; Morais J; Mueller C; Potpara TS; Rasmussen LH; Rubboli A; Tamargo J; Valgimigli M; Zamorano JL
    Eur Heart J; 2014 Dec; 35(45):3155-79. PubMed ID: 25154388
    [No Abstract]   [Full Text] [Related]  

  • 16. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
    Pamukcu B; Lane DA; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1703-10. PubMed ID: 21108552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
    Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kääb S; Schotten U; Wegscheider K; Boriani G; Ezekowitz M; Diener H; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Vardas P; Breithardt G; Camm AJ
    Thromb Haemost; 2011 Dec; 106(6):1012-9. PubMed ID: 22048744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Coca A; Kahan T; Boriani G; Manolis AS; Olsen MH; Oto A; Potpara TS; Steffel J; Marín F; de Oliveira Figueiredo MJ; de Simone G; Tzou WS; En Chiang C; Williams B
    Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):235-250. PubMed ID: 28541499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New evidence, new controversies: a critical review of the European Society of Cardiology 2010 clinical practice guidelines on atrial fibrillation.
    Anguita M; Worner F; Domenech P; Marín F; Ortigosa J; Pérez-Villacastín J; Fernández-Ortiz A; Alonso A; Cequier A; Comín J; Heras M; Pan M; Alzueta J; Arenal A; Barón G; Borrás X; Bover R; de la Figuera M; Escobar C; Fiol M; Herreros B; Merino JL; Mont L; Murga N; Pedrote A; Quesada A; Ripoll T; Rodríguez J; Ruiz M; Ruiz R
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):7-13. PubMed ID: 22099429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.